# Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

> **NCT00432913** · PHASE2,PHASE3 · COMPLETED · sponsor: **S.L.A. Pharma AG** · enrollment: 120 (estimated)

## Conditions studied

- Adenomatous Polyps

## Interventions

- **DRUG:** Eicosapentaenoic Acid (EPA)
- **PROCEDURE:** Endoscopy
- **PROCEDURE:** Biopsies taken
- **PROCEDURE:** Clinical chemistry
- **PROCEDURE:** Haematology
- **PROCEDURE:** Physical examination
- **PROCEDURE:** Vital signs
- **PROCEDURE:** Urine pregnancy test
- **PROCEDURE:** Completion of patient diary card

## Key facts

- **NCT ID:** NCT00432913
- **Lead sponsor:** S.L.A. Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2008-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00432913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00432913, "Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00432913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*